Clinical trial
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
NCT04507971 is registered in ClinicalTrials.gov with NuBiyota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
- Lead sponsor
- NuBiyota
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 22, 2020
- Completion date
- December 31, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.